-
2
-
-
0033785676
-
International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update
-
W.F. Keane, G.R. Bailie, E. Boeschoten International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update Perit Dial Int 20 2000 396 411
-
(2000)
Perit Dial Int
, vol.20
, pp. 396-411
-
-
Keane, W.F.1
Bailie, G.R.2
Boeschoten, E.3
-
3
-
-
0034763241
-
Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat
-
P.A. Bradford Extended-spectrum beta-lactamases in the 21st century Characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 951
-
(2001)
Clin Microbiol Rev
, vol.14
, pp. 933-951
-
-
Bradford, P.A.1
-
4
-
-
0037282428
-
Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment
-
M.E. Rupp, P.D. Fey Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae Considerations for diagnosis, prevention and drug treatment Drugs 63 2003 353 365
-
(2003)
Drugs
, vol.63
, pp. 353-365
-
-
Rupp, M.E.1
Fey, P.D.2
-
5
-
-
0026409956
-
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin)
-
A. Bauernfeind, S. Schweighart, E. Eberlein, R. Jungwirth In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin) Infection 19 Suppl 5 1991 264 275
-
(1991)
Infection
, vol.19
, Issue.5
, pp. 264-275
-
-
Bauernfeind, A.1
Schweighart, S.2
Eberlein, E.3
Jungwirth, R.4
-
6
-
-
0025274003
-
Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases
-
G.A. Jacoby, I. Carreras Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases Antimicrob Agents Chemother 34 1990 858 862
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 858-862
-
-
Jacoby, G.A.1
Carreras, I.2
-
8
-
-
0035684366
-
Pulmonary infectious mortality among patients with end-stage renal disease
-
M.J. Sarnak, B.L. Jaber Pulmonary infectious mortality among patients with end-stage renal disease Chest 120 2001 1883 1887
-
(2001)
Chest
, vol.120
, pp. 1883-1887
-
-
Sarnak, M.J.1
Jaber, B.L.2
-
9
-
-
0033764426
-
Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998
-
S. Zelenitsky, L. Barns, I. Findlay Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998 Am J Kidney Dis 36 2000 1009 1013
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 1009-1013
-
-
Zelenitsky, S.1
Barns, L.2
Findlay, I.3
-
10
-
-
0023181082
-
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
-
C. Brun-Buisson, P. Legrand, A. Philippon, F. Montravers, M. Ansquer, J. Duval Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae Lancet 2 1987 302 306
-
(1987)
Lancet
, vol.2
, pp. 302-306
-
-
Brun-Buisson, C.1
Legrand, P.2
Philippon, A.3
Montravers, F.4
Ansquer, M.5
Duval, J.6
-
11
-
-
1942422567
-
The effects of peritoneal dialysis solutions on peritoneal host defense
-
S. Mortier, N.H. Lameire, A.S. De Vriese The effects of peritoneal dialysis solutions on peritoneal host defense Perit Dial Int 24 2004 123 138
-
(2004)
Perit Dial Int
, vol.24
, pp. 123-138
-
-
Mortier, S.1
Lameire, N.H.2
De Vriese, A.S.3
-
12
-
-
0034285477
-
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
-
D.L. Paterson Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) Clin Microbiol Infect 6 2000 460 463
-
(2000)
Clin Microbiol Infect
, vol.6
, pp. 460-463
-
-
Paterson, D.L.1
-
13
-
-
0028097155
-
Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
-
E.S. Go, C. Urban, J. Burns Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam Lancet 344 1994 1329 1332
-
(1994)
Lancet
, vol.344
, pp. 1329-1332
-
-
Go, E.S.1
Urban, C.2
Burns, J.3
-
14
-
-
0032517251
-
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
-
J.J. Rahal, C. Urban, D. Horn Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1998 1233 1237
-
(1998)
JAMA
, vol.280
, pp. 1233-1237
-
-
Rahal, J.J.1
Urban, C.2
Horn, D.3
-
15
-
-
0033047527
-
The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen
-
S.C. Sanyal, E.M. Mokaddas The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen J Chemother 11 1999 28 33
-
(1999)
J Chemother
, vol.11
, pp. 28-33
-
-
Sanyal, S.C.1
Mokaddas, E.M.2
-
16
-
-
0035189967
-
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae
-
K.S. Thomson, E.S. Moland Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae Antimicrob Agents Chemother 45 2001 3548 3554
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 3548-3554
-
-
Thomson, K.S.1
Moland, E.S.2
-
17
-
-
0034034589
-
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia
-
D.L. Paterson, L. Mulazimoglu, J.M. Casellas Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia Clin Infect Dis 30 2000 473 478
-
(2000)
Clin Infect Dis
, vol.30
, pp. 473-478
-
-
Paterson, D.L.1
Mulazimoglu, L.2
Casellas, J.M.3
-
18
-
-
0026089266
-
Properties of plasmids responsible for production of extended-spectrum β-lactamases
-
G.A. Jacoby, L. Sutton Properties of plasmids responsible for production of extended-spectrum β-lactamases Antimicrob Agents Chemother 35 1991 164 169
-
(1991)
Antimicrob Agents Chemother
, vol.35
, pp. 164-169
-
-
Jacoby, G.A.1
Sutton, L.2
-
19
-
-
0033998662
-
Biochemical sequence analyses of GES-1, a novel Class a extended-spectrum β-lactamase, and the Class 1 integron In52 from Klebsiella pneumoniae
-
L. Poirel, I. Le Thomas, T. Naas, A. Karim, P. Nordmann Biochemical sequence analyses of GES-1, a novel Class A extended-spectrum β-lactamase, and the Class 1 integron In52 from Klebsiella pneumoniae Antimicrob Agents Chemother 44 2000 622 632
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 622-632
-
-
Poirel, L.1
Le Thomas, I.2
Naas, T.3
Karim, A.4
Nordmann, P.5
-
20
-
-
0034088492
-
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan
-
J.J. Yan, S.M. Wu, S.H. Tsai, J.J. Wu, I.J. Su Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan Antimicrob Agents Chemother 44 2000 1438 1442
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1438-1442
-
-
Yan, J.J.1
Wu, S.M.2
Tsai, S.H.3
Wu, J.J.4
Su, I.J.5
-
21
-
-
0035003640
-
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory
-
D.L. Paterson, W.C. Ko, A. Von Gottberg Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases Implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 2212
-
(2001)
J Clin Microbiol
, vol.39
, pp. 2206-2212
-
-
Paterson, D.L.1
Ko, W.C.2
Von Gottberg, A.3
-
22
-
-
0036780839
-
Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia
-
B.N. Kim, J.H. Woo, M.N. Kim, J. Ryu, Y.S. Kim Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia J Hosp Infect 52 2002 99 106
-
(2002)
J Hosp Infect
, vol.52
, pp. 99-106
-
-
Kim, B.N.1
Woo, J.H.2
Kim, M.N.3
Ryu, J.4
Kim, Y.S.5
-
23
-
-
0036449283
-
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome
-
B. Du, Y. Long, H. Liu Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection Risk factors and clinical outcome Int Care Med 28 2002 1718 1723
-
(2002)
Int Care Med
, vol.28
, pp. 1718-1723
-
-
Du, B.1
Long, Y.2
Liu, H.3
-
24
-
-
85007664318
-
Pharmacokinetics of 6315-S (flomoxef) during blood purification in uremic patients
-
T. Nobuhiro, N. Akira, I. Akio Pharmacokinetics of 6315-S (flomoxef) during blood purification in uremic patients Nippon Kagaku Ryoho Gakkai Zasshi 35 suppl 1 1987 518 522
-
(1987)
Nippon Kagaku Ryoho Gakkai Zasshi
, vol.35
, Issue.1
, pp. 518-522
-
-
Nobuhiro, T.1
Akira, N.2
Akio, I.3
|